BGC
MDT icon

Beutel, Goodman & Co’s Medtronic MDT Stock Holding History

Beutel, Goodman & Co’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$307M Sell
3,922,276
-546,898
-12% -$44.1M 2.26% 9
2026
Q1 		$387M Sell
4,469,174
-262,437
-6% -$25.1M 2.63% 7
2025
Q4 		$455M Sell
4,731,611
-33,494
-0.7% -$3.25M 2.79% 5
2025
Q3 		$454M Sell
4,765,105
-142,161
-3% -$13.1M 2.73% 4
2025
Q2 		$428M Buy
4,907,266
+115,209
+2% +$9.77M 2.44% 9
2025
Q1 		$431M Buy
4,792,057
+70,357
+1% +$6.3M 2.48% 9
2024
Q4 		$377M Buy
+4,721,700
New +$409M 2.05% 15
2018
Q1 		– Sell
-605
Closed -$39K – 72
2017
Q4 		$39K Buy
+605
New +$48.5K ﹤0.01% 71

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Beutel, Goodman & Co's MDT Position: Q2 2026 in Review

Beutel, Goodman & Co reduced its Medtronic (MDT) stake by 12% in Q2 2026, selling an estimated $44.1M and leaving 3,922,276 shares worth $307M. The position accounts for 2.26% of the portfolio, ranked #9.

Beutel, Goodman & Co first reported a position in MDT in Q4 2017 and has held it in 8 quarters since. The position peaked at $455M in Q4 2025. 2,133 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Beutel, Goodman & Co held 3,922,276 shares of Medtronic worth $307M as of Q2 2026.
  • Beutel, Goodman & Co sold 546,898 Medtronic shares in Q2 2026, an estimated $44.1M.
  • Medtronic made up 2.26% of Beutel, Goodman & Co's portfolio in Q2 2026, its #9 holding.
  • Beutel, Goodman & Co first reported a position in Medtronic in Q4 2017 and has held it in 8 quarters since.
  • Beutel, Goodman & Co's Medtronic position peaked at $455M in Q4 2025.
  • 2,133 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Beutel, Goodman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.